Largazole as a Promising Treatment for Angiogenic Diseases

Largazole is a macro cyclic depsipeptide, which is isolated from the marine cyanobacterium Symploca sp. Hydrolysis of Largazole leads to the production of Largazole thiol, a highly selective class I histone deacetylase (HDAC) inhibitor and an anti-proliferation agent. This review highlights the current understanding of Largazole in various vascular complications and its mechanism of action and discusses the challenges and future directions of Largazole-based therapeutics.

Author(s): Yuet Ping Kwan, Xiaomeng Wang

Abstract | Full-Text | PDF

Share This Article